Between Roper Technologies and Keysight Technologies, Which Stock Looks Set to Break Out?
Keysight Technologies surged 26% during the past Week. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Roper Technologies gives you more. Roper Technologies (ROP) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Keysight Technologies (KEYS) stock, suggesting you may be better off investing in ROP
- ROP’s quarterly revenue growth was 14.3%, vs. KEYS’s 10.3%.
- In addition, its Last 12 Months revenue growth came in at 14.0%, ahead of KEYS’s 8.0%.
- ROP leads on profitability over both periods – LTM margin of 28.1% and 3-year average of 28.3%.
These differences become even clearer when you look at the financials side by side. The table highlights how KEYS’s fundamentals stack up against those of ROP on growth, margins, momentum, and valuation multiples.
Valuation & Performance Overview
| KEYS | ROP | Preferred | |
|---|---|---|---|
| Valuation | |||
| P/EBIT Ratio | 59.3 | 17.1 | ROP |
| Revenue Growth | |||
| Last Quarter | 10.3% | 14.3% | ROP |
| Last 12 Months | 8.0% | 14.0% | ROP |
| Last 3 Year Average | -0.0% | 14.1% | ROP |
| Operating Margins | |||
| Last 12 Months | 16.3% | 28.1% | ROP |
| Last 3 Year Average | 19.3% | 28.3% | ROP |
| Momentum | |||
| Last 3 Year Return | 91.5% | -18.2% | KEYS |
Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: KEYS Revenue Comparison | ROP Revenue Comparison
See more margin details: KEYS Operating Income Comparison | ROP Operating Income Comparison
- Get Paid 9.0% to Buy ADSK at a 30% Discount – Here’s How
- The Smart Way to Own LLY: Collect 8.8% Before You Even Buy
- Cash Machine Trading Cheap – GoDaddy Stock Set to Run?
- Meta Platforms Stock Capital Return Hits $184 Bil
- Eli Lilly Stock Hands $51 Bil Back – Worth a Look?
- Alphabet Stock Hands $364 Bil Back – Worth a Look?
See detailed fundamentals on Buy or Sell ROP Stock and Buy or Sell KEYS Stock. Below we compare market return and related metrics across years.
Historical Market Performance
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | Avg | Best | |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| KEYS Return | 56% | -17% | -7% | 1% | 26% | 48% | 128% | <=== | |
| ROP Return | 15% | -12% | 27% | -4% | -14% | -24% | -19% | ||
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 83% | ||
| Monthly Win Rates [3] | |||||||||
| KEYS Win Rate | 75% | 50% | 50% | 50% | 67% | 100% | 65% | <=== | |
| ROP Win Rate | 58% | 42% | 75% | 58% | 42% | 0% | 46% | ||
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | 62% | ||
| Max Drawdowns [4] | |||||||||
| KEYS Max Drawdown | -1% | -37% | -30% | -25% | -21% | 0% | -19% | ||
| ROP Max Drawdown | -14% | -27% | -3% | -6% | -15% | -29% | -15% | ||
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | -7% | <=== | |
[1] Cumulative total returns since the beginning of 2021
[2] 2026 data is for the year up to 2/25/2026 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read ROP Dip Buyer Analyses to see how the stock has fallen and recovered in the past.
Still not sure about KEYS or ROP? Consider portfolio approach.
Smart Investing Begins With Portfolios
Stocks can jump or crash but long term success comes from staying invested. The right portfolio helps you ride gains and cushion single stock drops.
Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.